You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

APX005M

Showing 1 - 25 of 5,519
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Houston (APX005M, Pembrolizumab)

Recruiting
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Ovarian Cancer Trial in Copenhagen (APX005M)

Not yet recruiting
  • Ovarian Cancer
  • APX005M
  • Copenhagen, Sjaelland, Denmark
    NSGO-CTU
Apr 19, 2022

Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in

Recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Soft Tissue Sarcoma Trial in New York (Doxorubicin, APX005M)

Recruiting
  • Soft Tissue Sarcoma
  • New York, New York
    Columbia University Medical Center
Nov 12, 2021

Unresectable Melanoma, Metastatic Melanoma Trial in Poland, Spain (APX005M)

Active, not recruiting
  • Unresectable Melanoma
  • Metastatic Melanoma
  • APX005M
  • Warsaw, Poland
  • +12 more
Mar 8, 2022

Advanced Melanoma, Renal Cell Carcinoma Trial in New Haven (Nivolumab, Ipilimumab, APX005M)

Recruiting
  • Advanced Melanoma
  • Renal Cell Carcinoma
  • New Haven, Connecticut
  • +1 more
Nov 2, 2021

Cancer, Non Small Cell Lung Cancer Metastatic, Metastatic Melanoma Trial in Spain, United States (APX005M, Nivolumab)

Completed
  • Cancer
  • +4 more
  • Tucson, Arizona
  • +22 more
Dec 3, 2021

Locally Advanced Rectal Adenocarcinoma Trial in United States (APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days, mFOLFOX and

Recruiting
  • Locally Advanced Rectal Adenocarcinoma
  • APX005M, mFOLFOX, and Radiation Therapy 5Gy x 5 days
  • mFOLFOX and Radiation Therapy 5Gy x 5 days
  • Winston-Salem, North Carolina
  • +2 more
Sep 14, 2021

Metastatic Melanoma Trial in United States (NEO-PV-01, Nivolumab, Adjuvant)

Terminated
  • Metastatic Melanoma
  • NEO-PV-01
  • +4 more
  • Scottsdale, Arizona
  • +7 more
Sep 1, 2020

Cancer, NSCLC, Melanoma Trial in Duarte, Cleveland, Philadelphia (APX005M)

Completed
  • Cancer
  • +5 more
  • APX005M
  • Duarte, California
  • +2 more
Apr 27, 2020

Amyotrophic Lateral Sclerosis Trial in Canada, United States (ANX005)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Phoenix, Arizona
  • +10 more
Jul 1, 2022

Elevated Intraocular Pressure Trial in United States (Latanoprost ophthalmic solution, 0.005%, TC-002 latanoprost ophthalmic

Active, not recruiting
  • Elevated Intraocular Pressure
  • Latanoprost ophthalmic solution, 0.005%
  • TC-002 latanoprost ophthalmic solution, 0.005%
  • Garden Grove, California
  • +19 more
May 23, 2022

Amyotrophic Lateral Sclerosis Trial in Boston (Trehalose)

Temporarily not available
  • Amyotrophic Lateral Sclerosis
  • Boston, Massachusetts
    Sean M. Healey & AMG Center for ALS Neurological Clinical Resear
Dec 14, 2022

Glaucoma Trial in United States (Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%)

Active, not recruiting
  • Glaucoma
  • Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%
  • Mission Hills, California
  • +20 more
Jan 6, 2023

Foot Fracture, Pain, Acute Trial in Warsaw (Tramadol Hydrochloride, Placebo)

Completed
  • Foot Fracture
  • Pain, Acute
  • Tramadol Hydrochloride
  • Placebo
  • Warsaw, Mazowieckie, Poland
    Dept.of Anesthesia and Intensive Care, Warsaw Medical University
Oct 27, 2021

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Long-Term Development of Muscular Dystrophy Outcome Assessments

Not yet recruiting
  • LGMD1A
  • +33 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Aug 3, 2023

    Respiratory Syncytial Viruses Trial in Australia (RSV F Vaccine with Aluminum Phosphate Adjuvant, RSV F Vaccine, Matrix-M1

    Completed
    • Respiratory Syncytial Viruses
    • RSV F Vaccine with Aluminum Phosphate Adjuvant
    • +3 more
    • Sydney, New South Wales, Australia
    • +4 more
    Dec 2, 2021

    Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

    Active, not recruiting
    • Mycobacterium Infections, Nontuberculous
    • Birmingham, Alabama
    • +110 more
    Jan 23, 2023

    Study on Patterns of Care in Mild Asthmatic Patients

    Completed
    • Asthma
      • Berlin, Germany
      • +58 more
      Sep 26, 2022

      NonSegmental Vitiligo Trial in Canada, United States (INCB054707, Placebo)

      Active, not recruiting
      • NonSegmental Vitiligo
      • Hoover, Alabama
      • +30 more
      Nov 14, 2022

      Tuberculosis, Hiv Trial in Kobape (CRP and Molbio Truenat MTB, CRP and Xpert ULTRA MTB/RIF, standard test Xpert)

      Completed
      • Tuberculosis
      • Hiv
      • CRP and Molbio Truenat MTB
      • +3 more
      • Kobape, Nassarawa, Nigeria
        Zankli Research Centre
      Jul 30, 2021

      Low Back Pain Trial in Worldwide (Matching Placebo, Low Dose GRT6005, Medium Dose GRT6005)

      Completed
      • Low Back Pain
      • Matching Placebo
      • +4 more
      • Senftenberg, Austria
      • +78 more
      Jul 13, 2021

      Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

      Active, not recruiting
      • Advanced Solid Tumors
      • +7 more
      • Duarte, California
      • +87 more
      Aug 19, 2022